---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-007607"
form_type: "8-K"
ticker: "HRGN"
cik: "0001563665"
company_name: "Harvard Apparatus Regenerative Technology, Inc."
filed_at: "2023-03-14T23:59:59+00:00"
generated_at: "2026-06-18T03:16:35.870960+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Biostage appoints Jerry He as CEO, replacing David Green; sets compensation terms

## Summary
- Jerry He appointed Chairman and CEO effective March 1, 2023; David Green remains on board.
- Base salary $300,000, rising to $500,000 if private placement raises ≥$4M.
- Time-based option grant: 732,384 shares; milestone grant up to 488,256 shares.
- If offering raises <$4M, annual option grant valued at $200,000 in lieu of additional cash.
- Annual bonus up to 100% of base salary.

## SEC filing metadata
- accession: 0001493152-23-007607
- form_type: 8-K
- ticker: HRGN
- cik: 0001563665
- company_name: Harvard Apparatus Regenerative Technology, Inc.
- filed_at: 2023-03-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563665/000149315223007607/0001493152-23-007607-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563665/000149315223007607/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-007607
- JSON: https://secwatch.observer/filing/0001493152-23-007607.json
- Plain text: https://secwatch.observer/filing/0001493152-23-007607.txt

## Key facts
- Executive change
  David Green changed role as Chairman and Chief Executive Officer at Harvard Apparatus Regenerative Technology, Inc..
  - Action: replaced
  - Role: Chairman and Chief Executive Officer
  source text: the Company’s existing director, Junli (Jerry) He, was appointed Chairman and Chief Executive Officer of the Company, in replacement of David Green in such roles.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1563665/000149315223007607/0001493152-23-007607-index.htm
- Executive change
  Junli (Jerry) He was appointed as Chairman and Chief Executive Officer at Harvard Apparatus Regenerative Technology, Inc..
  - Action: appointed
  - Role: Chairman and Chief Executive Officer
  source text: the Company’s existing director, Junli (Jerry) He, was appointed Chairman and Chief Executive Officer of the Company, in replacement of David Green in such roles.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1563665/000149315223007607/0001493152-23-007607-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.